Drug discovery requires rigorous testing and comprehensive data analysis to ensure that potential drug candidates can progress to clinical trials. Drugs must be screened for their drug-target binding affinity to predict their efficacy.
The kinetics of drug-target binding and binding affinities are usually studied during the later stages of the drug discovery workflow. However, recent developments that optimise the analysis of receptor binding kinetics are proving beneficial for drug discovery research.Download this eBook to learn about:
- The role of binding kinetics in drug discovery
- The current methods for measuring kinetic parameters
- Some of the novel approaches that have been developed and their applications